Literature DB >> 3295445

Interleukin-1 (IL-1) depresses cytochrome P450 levels and activities in mice.

S I Shedlofsky, A T Swim, J M Robinson, V S Gallicchio, D A Cohen, C J McClain.   

Abstract

Endotoxin depresses cytochrome P450 levels when injected into animals. The purpose of this study was to determine whether endotoxin itself, or monokine(s) released in response to endotoxin administration are responsible for this effect. Cytochrome P450 levels and drug metabolizing activities were measured in endotoxin resistant C3H/HeJ mice 24h after single intraperitoneal injections of either lipopolysaccharide (LPS), a semipurified murine monokine preparation containing interleukin-1 (IL-1), or murine recombinant IL-1. In endotoxin sensitive C3H/HeN mice, LPS (0.5 mg/Kg) decreased total cytochrome P450 levels, benzphetamine demethylase activities, and ethoxyresorufin-0-deethylase activities. This dose of LPS did not alter cytochrome P450 levels or activities in the C3H/HeJ mice. However, after injection of the semipurified monokine preparation or the recombinant IL-1, there were significant decreases in cytochrome P450 levels and activities similar to the decreases observed with LPS in the C3H/HeN mice. These findings suggest that the alterations in hepatic cytochrome P450 seen with endotoxin injection are mediated, at least in part, by IL-1.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3295445     DOI: 10.1016/0024-3205(87)90506-6

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  13 in total

1.  Lupeol, a triterpenoid isolated from Calotropis gigantea latex ameliorates the primary and secondary complications of FCA induced adjuvant disease in experimental rats.

Authors:  Venkatesan Saratha; Sorimuthu Pillai Subramanian
Journal:  Inflammopharmacology       Date:  2011-10-16       Impact factor: 4.473

2.  Regulation of cytochrome P450 4F11 by nuclear transcription factor-κB.

Authors:  Jordan C Bell; Henry W Strobel
Journal:  Drug Metab Dispos       Date:  2011-10-19       Impact factor: 3.922

3.  Immunostimulating lipopeptide, LtriP (RP 56142): comparison of the effect on hepatic cytochrome P 450 modulation and radioprotection in male and female of three mouse strains.

Authors:  M Sedqi; M Delaforge; D Mansuy; B Martin; P Jollès; D Migliore-Samour
Journal:  Experientia       Date:  1995-08-16

4.  The effect of high dose endotoxin on CYP3A2 expression in the rat.

Authors:  A L Roe; G Warren; G Hou; G Howard; S I Shedlofsky; R A Blouin
Journal:  Pharm Res       Date:  1998-10       Impact factor: 4.200

Review 5.  Pharmacokinetic alterations after severe head injury. Clinical relevance.

Authors:  B A Boucher; S D Hanes
Journal:  Clin Pharmacokinet       Date:  1998-09       Impact factor: 6.447

6.  In vivo effects of immunostimulating lipopeptides on mouse liver microsomal cytochromes P-450 and on paracetamol-induced toxicity.

Authors:  D Migliore-Samour; M Delaforge; M Jaouen; D Mansuy; P Jollès
Journal:  Experientia       Date:  1989-09-15

7.  Endotoxin administration to humans inhibits hepatic cytochrome P450-mediated drug metabolism.

Authors:  S I Shedlofsky; B C Israel; C J McClain; D B Hill; R A Blouin
Journal:  J Clin Invest       Date:  1994-12       Impact factor: 14.808

Review 8.  Clinical toxicity of the interferons.

Authors:  T Vial; J Descotes
Journal:  Drug Saf       Date:  1994-02       Impact factor: 5.606

9.  TLR4-dependent and -independent regulation of hepatic cytochrome P450 in mice with chemically induced inflammatory bowel disease.

Authors:  Madhusudana R Chaluvadi; Beatrice A Nyagode; Ryan D Kinloch; Edward T Morgan
Journal:  Biochem Pharmacol       Date:  2008-11-06       Impact factor: 5.858

10.  Interleukin-1 and tumour necrosis factor induce hepatic haem oxygenase. Feedback regulation by glucocorticoids.

Authors:  L Cantoni; C Rossi; M Rizzardini; M Gadina; P Ghezzi
Journal:  Biochem J       Date:  1991-11-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.